Proteome-wide mendelian randomization identifies FCRL3 and LY9 as potential therapeutic targets for lymphoma
Abstract Background Lymphoma is a common hematologic malignancy with limited treatment options. The research objective was to ascertain plasma proteins that could be targeted for lymphoma treatment. Methods We conducted proteome-wide mendelian randomization (PW-MR) analyses on blood proteins from th...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer
2025-11-01
|
| Col·lecció: | Discover Oncology |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1007/s12672-025-03931-z |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|